This may serve as a crucial insight for future understanding of how HMGB2 promotes immunosuppression in the local immune microenvironment of HCC, thereby facilitating tumor invasion, metastasis, or resistance to immunotherapy. The gene discussed is HMGB2; the disease is neoplasm.